Literature DB >> 34495281

Postmarketing Cases of Enfortumab Vedotin-Associated Skin Reactions Reported as Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis.

Michelle Nadeau Nguyen1, Melissa Reyes1, S Christopher Jones1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34495281      PMCID： PMC8427493          DOI： 10.1001/jamadermatol.2021.3450

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN： 2168-6068            Impact factor:   11.816


× No keyword cloud information.
  1 in total

1.  Regarding "Management of Dermatologic Events Associated with the Nectin-4-directed Antibody-Drug Conjugate Enfortumab Vedotin".

Authors:  Saskia Ingen-Housz-Oro; Constance Thibault; Pierre Sohier; Nicolas Dupin
Journal:  Oncologist       Date:  2022-10-01       Impact factor: 5.837
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.